Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,151 | 697 | 99.9% |
| Education | $11.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,312 | 72 | $0 (2024) |
| Novo Nordisk Inc | $918.92 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $824.27 | 47 | $0 (2024) |
| ABBVIE INC. | $673.41 | 40 | $0 (2024) |
| Lilly USA, LLC | $670.73 | 52 | $0 (2024) |
| PFIZER INC. | $591.23 | 57 | $0 (2024) |
| Merck Sharp & Dohme LLC | $494.88 | 43 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $476.55 | 36 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $398.94 | 28 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $374.64 | 27 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $990.16 | 47 | AstraZeneca Pharmaceuticals LP ($240.66) |
| 2023 | $945.06 | 57 | Novo Nordisk Inc ($146.66) |
| 2022 | $1,315 | 82 | ABBVIE INC. ($226.52) |
| 2021 | $1,419 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($228.44) |
| 2020 | $837.06 | 54 | AstraZeneca Pharmaceuticals LP ($184.34) |
| 2019 | $1,530 | 115 | AstraZeneca Pharmaceuticals LP ($260.85) |
| 2018 | $1,576 | 117 | AstraZeneca Pharmaceuticals LP ($258.06) |
| 2017 | $1,550 | 129 | SANOFI-AVENTIS U.S. LLC ($218.68) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ANTIBIOTIC | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Obesity | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device) | Food and Beverage | Cash or cash equivalent | $38.00 | General |
| Category: PULMONOLOGY | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardio-renal | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 05/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Insomnia | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PSYCHIATRY | ||||||
| 04/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 518 | 1,142 | $185,114 | $79,467 |
| 2022 | 13 | 506 | 1,097 | $171,726 | $77,224 |
| 2021 | 11 | 473 | 1,024 | $151,172 | $67,358 |
| 2020 | 15 | 594 | 1,148 | $156,167 | $63,169 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 618 | $127,926 | $50,129 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 166 | $22,576 | $9,610 | 42.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 38 | 41 | $6,970 | $5,464 | 78.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 32 | $8,896 | $4,044 | 45.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 22 | 39 | $3,120 | $2,043 | 65.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 24 | 30 | $3,000 | $1,978 | 65.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 20 | 20 | $2,300 | $1,803 | 78.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,782 | $1,494 | 53.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 97 | $4,171 | $908.20 | 21.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $949.00 | $743.99 | 78.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $834.75 | $616.56 | 73.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $561.00 | $371.49 | 66.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $384.00 | $210.00 | 54.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 23 | $644.00 | $50.60 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 567 | $115,101 | $45,572 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 145 | $19,285 | $8,609 | 44.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 48 | 54 | $9,150 | $6,861 | 75.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 38 | 82 | $8,136 | $5,554 | 68.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 37 | 38 | $4,350 | $3,034 | 69.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $5,460 | $2,509 | 46.0% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 13 | 16 | $2,310 | $1,447 | 62.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 27 | $2,140 | $1,307 | 61.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $726.00 | $711.48 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 34 | 69 | $2,898 | $662.09 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $858.00 | $615.47 | 71.7% |
About Dr. Sean Callahan, M.D
Dr. Sean Callahan, M.D is a Family Medicine healthcare provider based in Oak Harbor, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194811828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Callahan, M.D has received a total of $10,162 in payments from pharmaceutical and medical device companies, with $990.16 received in 2024. These payments were reported across 699 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,151).
As a Medicare-enrolled provider, Callahan has provided services to 2,091 Medicare beneficiaries, totaling 4,411 services with total Medicare billing of $287,217. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oak Harbor, OH
- Active Since 10/04/2006
- Last Updated 10/06/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194811828
Products in Payments
- JARDIANCE (Drug) $891.71
- FARXIGA (Drug) $787.10
- XIFAXAN (Drug) $422.37
- VRAYLAR (Drug) $394.90
- JANUVIA (Drug) $366.97
- CHANTIX (Drug) $329.80
- Ozempic (Drug) $314.58
- ELIQUIS (Drug) $313.91
- XARELTO (Drug) $307.75
- UBRELVY (Drug) $259.62
- Kerendia (Drug) $243.84
- ENTRESTO (Drug) $230.61
- TOUJEO (Drug) $213.27
- SYMBICORT (Drug) $210.85
- Otezla (Drug) $210.31
- BREZTRI (Drug) $202.86
- NURTEC ODT (Drug) $194.73
- TRULICITY (Drug) $176.95
- INVOKANA (Drug) $162.78
- EMGALITY (Drug) $162.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oak Harbor
Chad Blunt, M.d, M.D
Family Medicine — Payments: $10,566
Mr. Robert Lycksell, Md, MD
Family Medicine — Payments: $4,867
Douglas Langrock, Md, MD
Family Medicine — Payments: $4,059
Dr. Krishna Ragothaman, Md, MD
Family Medicine — Payments: $3,902
David Lemme, D.o., M.p.h, D.O., M.P.H
Family Medicine — Payments: $548.65
Janette Reeves, D.o, D.O
Family Medicine — Payments: $539.62